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Abstract
Skeletal muscle metastases from tumors are a rare occurrence and can present difficult management decisions. We
report here on a patient that had been previously treated for squamous cell laryngeal cancer with surgical resec-
tion and adjuvant systemic chemotherapy that presented with a metastasis to the rectus abdominis muscle with-
out evidence of recurrent disease at the primary site. After a metastatic workup with PET/CT scan suggested this to
be an isolated lesion, surgical excision with negative margins was performed based upon limited treatment
options secondary to the location of the tumor and his favorable prognosis suggested by his pathological staging
at the time of the initial resection. Here we discuss the incidence of distant metastases from laryngeal cancer and
appropriate screening methods. Additionally, skeletal muscle metastases and treatment considerations are
discussed.
Introduction
Skeletal muscle metastases from cancer occur rarely and
there are no clear guidelines for appropriate work-up
and management of these lesions. Specifically, soft mus-
cle metastases to the abdominal region provide excep-
tionally difficult treatment decisions based on location.
While these can occur following percutaneous or surgi-
cal procedures in patients with head and neck cancers,
it is extremely rare that one should occur in a patient
without a history of any such procedures. Soft tissue
metastases to muscle and skin generally represent undis-
covered disease elsewhere and an overall poor prognosis.
The case presented here occurred in a patient that had
been successfully treated and had no signs of other
recurrence on clinical exam or imaging studies. There-
fore, this case presented a rare and difficult treatment
strategy.
Report of Case
A 52-year-old male with a history of laryngeal cancer
was found on routine physical examination to have a 2
cm subcutaneous nodule in the left mid-abdomen
approximately 2 cm superior and 4 cm lateral to the
umbilicus. The mass was non-mobile and slightly tender
to palpation. There was no erythema, induration, or
cutaneous changes. The lesion had been asymptomatic
and the patient had not been aware of this finding.
Computed tomography (CT) scan of the abdomen and
pelvis with intravenous contrast was performed, with
the only pertinent finding being the mass localized
within left rectus abdominis muscle (Figure 1A). This
radiographic appearance of this was interpreted as a
fluid filled lesion, concerning for abscess, hematoma, or
seroma. Otolaryngology and general surgery consulta-
tions were obtained.
The patient’s history was significant for a squamous
cell carcinoma of the larynx, treated operatively seven
months prior to this presentation with a total laryngect-
omy and bilateral selective neck dissections of levels 2
through 4. The patient had also received adjuvant che-
motherapy and local radiation. Pathology revealed a
moderately to poorly differentiated squamous cell cancer
of the larynx, pathologic stage T3N2bMx, with involve-
ment of 2 out of 60 lymph nodes in the surgical speci-
men. The patient had been followed regularly by his
primary care physician, otolaryngologist, and medical
oncologist with no evidence of a local recurrence until
the point of presentation. Of note, the patient did not
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have a history of a trans-abdominal feeding tube or any
instrumentation of his abdominal wall.
Based upon the patient’s above history, physical exam-
ination and CT scan appearance of the mass a fine nee-
dle biopsy was performed that revealed a moderately
differentiated squamous cell carcinoma. Restaging of the
patient’s cancer was done by positron emission tomo-
graphy/computed tomography (PET/CT) scan, which
demonstrated significant fluorodeoxyglucose (FDG)
uptake to the left rectus muscle with no evidence of
focal uptake in the neck or elsewhere (Figure 1B). On
CT, the lesion appeared to be confined to the rectus
muscle within the rectus sheath, with no peritoneal or
cutaneous involvement.
Given the finding of the isolated metastasis and the
location of the mass, which limited the option of radia-
tion treatment secondary to the high risk of radiation
induced enteritis, the decision was made to proceed with
surgical excision. Complete surgical excision of the lesion
with minimal loss of fascia allowing for primary closure.
The tumor at pathology was a 4.5 × 3.5 × 2.5 cm meta-
static intramuscular squamous cell carcinoma. Histology
from the original bilateral neck dissection (Figure 2A)
was reviewed along with the current specimen (Figure
2B) and demonstrated that the histology from the mass
was similar to that of the original laryngeal specimen.
The tumor had not involved the peritoneum determined
by negative margins at the posterior sheath. The tumor
did involve the anterior sheath but not the skin. The
patient recovered well and was discharged from the hos-
pital. When seen in follow up, the patient was doing well
and had no evidence of further disease.
Discussion
Laryngeal cancer is the second most common type of
head and neck malignancy, accounting for 25-45% of all
head and neck tumors [1,2]. Squamous cell carcinoma is
by far the most common histologic type, accounting for
up to 90% of the cancers in this region [1]. Smoking
and alcohol consumption are significant risk factors
associated with approximately 85% of all laryngeal carci-
nomas [1,2]. Interestingly, whereas other cancer survival
rates have improved significantly over the past 30 years,
laryngeal cancer has demonstrated no appreciable
decrease in mortality since the 1970’s and it continues
to be approximately 65% survival at 5 years [1].
Most commonly abdominal wall metastases for head
and neck cancers, including laryngeal, occur after percu-
taneous, laparoscopic, or incisional procedures. Meta-
static disease at the site of a percutaneous endoscopic
gastrostomy (PEG) tube placement is known to occur
with many different types of head and neck cancers
[3-6], most widely hypothesized to be due to direct
seeding by endoscopic dislodgement and displacement
of cancer cells [3]. Incidence of metastatic lesions from
head and neck cancers to PEG sites is unknown but
estimated to be 1-3% [7,8]. It has been suggested that in
these cancers, either laparoscopic [5] or radiologic [8]
tube placement offers a safer alternative, although
recently a case of gastrostomy-site metastasis following
radiological insertion has been reported [9].
Distant metastases from head and neck cancer occur
in 11-26% of patients [10,11], though one study demon-
strated an incidence of distant metastases to be only 5%
in patients for whom initial treatment had achieved
Figure 1 Imaging of left rectus abdominus mass. A.) CT scan performed during ED visit demonstrating a 14 mm lesion in the left rectus
muscle. B.) Subsequent PET-CT demonstrated significant 18-FDG uptake at the site of the lesion found on CT. No other sites of abnormal uptake
were found.
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loco-regional control [12]. The majority of these occur
within 2 years [12], and the most common sites for
metastases are the lung (45-85%), bones (10-30%), and
liver (5-22%) [11-14]. Retrospective studies suggest that
epidemiologic factors such as gender, age, or tobacco or
alcohol use do not affect the incidence of distant metas-
tases [12], but instead clinical TNM staging [15], patho-
logic TNM staging [12], or histologic grade of primary
tumor [15] appear more closely related. The role of
adjuvant radiation therapy in patients with advanced lar-
yngeal cancer at presentation has been debated. One
study demonstrated that it does not significantly affect
the incidence of distant metastases but increases the
risk of local recurrence and second primaries [16].
Whereas squamous cell carcinoma of the larynx has
similar metastatic patterns to head and neck cancer in
general, the incidence of metastases may be slightly
lower [13]. Few reports of soft tissue metastases from
laryngeal cancer exist, though the skin has been
described as an infrequent but poor prognostic location
for a metastatic lesion [13]. One case report describes
metastatic laryngeal cancer to the gluteus maximus and
the patient was successfully treated with surgical exci-
sion [14]. Another case report describes laryngeal cancer
metastatic to the scapular muscles following treatment
with total laryngectomy and bilateral neck dissection
[17]. Only 3 cases can be found describing other head
and neck cancers metastatic to skeletal muscles, all with
varying treatments and outcomes [14]. Additionally, in a
series of 500 autopsies on patients with malignant dis-
ease, 2 cases of distant metastases involving muscle are
described in patients with head and neck cancers, one
involving the rectus abdominus (cited in [14]).
Screening for distant metastases in head and neck
cancers, and laryngeal cancer more specifically, is cur-
rently not well established. According to one study, a
CT scan of the thorax is the single most important
study that can be done [11]. There are few evidence
based guidelines regarding imaging in soft tissue metas-
tases after clinical detection. Some have advocated for a
whole body magnetic resonance imaging (MRI) as the
preferred study for evaluation [18]; however, PET/CT
requires further study for its clinical benefit [19]. One
recent manuscript contrasts the two modalities and con-
cludes that PET/CT, in offering metabolic information,
can be more useful in tumor localization, T-stage, and
lymph node assessment [19]. In contrast, MRI can be
more useful in diagnosing soft tissue metastases and dif-
ferentiating metastatic disease from sarcomas and other
processes [18,19]. In a recent study on imaging modal-
ities for recurrent head and neck cancers, addition of
PET/CT to traditional imaging modalities was found to
significantly change the clinical management in 38.7% of
patients [20]. The sensitivity and specificity of PET/CT
Figure 2 Pathology consistent with metastatic laryngeal cancer. A.) H & E stain histology from bilateral neck dissection demonstrating
squamous cell laryngeal cancer. Corner image represents higher magnification view. B.) H & E stain histology of mass removed from the left
rectus muscle, demonstrating invasive squamous cell cancer within muscle, consistent with metastatic laryngeal cancer. Corner image represents
higher magnification view.
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for distant metastatic disease was 100% and 88.89%
respectively [20]. Our patient received a PET/CT which
demonstrated significant uptake only at the site of the
abdominal wall mass, without any other identifiable
lesions or lymphadenopathy. CT scan showed the lesion
to be confined within the rectus sheath without any
cutaneous or intraperitoneal involvement.
The treatment options for distant soft tissue metas-
tases from all cancers are highly individualized as there
is little published data. Perhaps the largest study pub-
lished regarding distant soft tissue metastases included
30 new patients and a review of 91 case reports [18].
This study found that soft tissue metastases were most
commonly the presenting symptom from an occult
malignancy, unlike this patient that presented with a
soft tissue metastasis following surgical treatment. Gen-
erally, soft tissue metastases were associated with a
prognosis of 64% mortality in literature cases and 70%
mortality in new patients within a mean follow-up of
7.2 and 5.4 months respectively. The authors of this
case series recommend surgical excision of a soft tissue
metastasis in select patients with good prognoses and
solitary metastases after long disease-free intervals and
appropriate treatment of the primary carcinoma. In gen-
eral, they recommend chemotherapy, radiation therapy,
or a combination as the preferred treatment option [18].
In the case presented above, the use of radiation as a
therapeutic modality was limited given the location of
the lesion with underlying small bowel that would be
included in the radiation field. Additionally, this was an
isolated lesion in a patient that had undergone appropri-
ate treatment of the primary malignancy who was at
relatively low cardiopulmonary risk. Of the 5 reported
cases of head and neck carcinoma metastatic to skeletal
muscles, 2 were treated operatively with one patient sur-
viving disease free at 13 months of follow up while the
other operative patient had died at 7 months from dis-
ease spread.
Conclusions
This paper describes a case of a laryngeal cancer meta-
static to the rectus muscle following appropriate treat-
ment for the primary tumor. There are few described
cases of distant soft tissue metastases in the literature,
and therefore no evidence based guidelines exists for
these occurrences. Whereas soft tissue metastases for all
cancers are generally a sign of widespread disease and
therefore a poor prognostic indicator, we used PET/CT
to define this as an isolated lesion. The patient under-
went surgical excision of the lesion with negative mar-
gins. At this point, given the low incidence of isolated
soft tissue metastasis in the literature, we recommend
complete whole body physical examination as an adjunct
to routine follow up for head and neck cancers;
however, we advocate the use of PET/CT scanning if
evidence of metastatic disease is found. Treatment
options need to be individualized based upon the ade-
quacy of the initial treatment regimen, disease free
interval, location of the metastasis, and the patient’s car-
diopulmonary risk and performance status.
Consent
The authors of this report attempted to contact the
patient or next of kin and were unable to contact the
patient at the current contact information. He is no
longer followed by the surgical clinic. Therefore, consent
was unable to be obtained.
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